A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Rebamipide Treatment for Low-Dose Aspirin-Induced Moderate-to-Severe Small Intestinal Damage

• Toshio Watanabe ,

  * E-mail: watanabet@med.osaka-cu.ac.jp

  Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan

  ⨯
• Toshihisa Takeuchi,

  Affiliation Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan

  ⨯
• Osamu Handa,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Yasuhisa Sakata,

  Affiliation Department of Internal Medicine and Gastroenterology, Saga Medical School, Saga, Japan

  ⨯
• Tetsuya Tanigawa,

  Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan

  ⨯
• Masatsugu Shiba,

  Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan

  ⨯
• Yuji Naito,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Kazuhide Higuchi,

  Affiliation Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan

  ⨯
• Kazuma Fujimoto,

  Affiliation Department of Internal Medicine and Gastroenterology, Saga Medical School, Saga, Japan

  ⨯
• Toshikazu Yoshikawa,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Tetsuo Arakawa

  Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan

  ⨯